|
Quotes & Info
|
| IFLG > SEC Filings for IFLG > Form 8-K on 23-Dec-2008 | All Recent SEC Filings |
23-Dec-2008
Other Events
On November 28, 2008, InfoLogix, Inc. received an agreement from Endo Pharmaceuticals, Inc. ("Endo") for the deployment of 850 wireless enterprise class mobile devices to support their expanded sales force in North America. InfoLogix will provide Endo a fully integrated, hand-held pen-based mobile solution which leverages the latest advancements in wireless mobile technology, and is supported by an extended maintenance program.
Equipping Endo with a new mobile technology platform for their field sales force enhances their capabilities to fulfill detailing requirements and product sample verification through the use of a signature capture capability built into the device.
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: December 23, 2008 By: /s/ John A. Roberts John A. Roberts Chief Financial Officer
|
|